Sugi Predict

Sugi Predict / Compounds / Sampatrilat

Sampatrilat

Sampatrilat

SCHEMBL7301333

CS(=O)(=O)N[C@@H](CCCCN)C(=O)NCC(CC1(C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)CCCC1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ECE1 P42892 4/20 1.00
▸ ACE P12821 3/20 1.00
▸ MME P08473 3/20 1.00
▸ NPPA P01160 1/20 1.00
▸ ITGB3 P05106 1/20 0.44
▸ ITGA2B P08514 1/20 0.44
▸ ITGB1 P05556 2/20 0.39
▸ ITGA4 P13612 2/20 0.39
▸ CHRND Q07001 5/20 0.39
▸ CPB2 Q96IY4 1/20 0.39
▸ CHRNA1 P02708 1/20 0.39
▸ CHRNG P07510 1/20 0.39
▸ CHRNB1 P11230 1/20 0.39
▸ MMP1 P03956 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sampatrilat SCHEMBL4567110 1.00 ECE1 (1.00) ECE1ACEMMENPPAITGB3
Sampatrilat SCHEMBL49066 1.00 ECE1 (1.00) ECE1ACEMMENPPAITGB3
SCHEMBL7294367 0.95 ACE (0.91) ECE1ACEMMENPPAITGB3
SCHEMBL7302871 0.90 MME (0.82) ECE1ACEMMENPPAITGB3
SCHEMBL7302883 0.90 MME (0.82) ECE1ACEMMENPPAITGB3
SCHEMBL9755064 0.90 MME (0.81) ECE1ACEMMENPPAITGB1
SCHEMBL6441043 0.90 ACE (0.81) ECE1ACEMMENPPAITGB3
SCHEMBL9755065 0.90 MME (0.81) ECE1ACEMMENPPAITGB1
SCHEMBL7294361 0.89 MME (0.80) ECE1ACEMMENPPAITGB3
SCHEMBL10471733 0.88 ECE1 (0.77) ECE1ACEMMENPPAITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0358398-B1 CYCLOALKYL-SUBSTITUTED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS Pfizer Limited (GB) 1993-03-10 — — EP claimed
EP-0358398-A1 Cycloalkyl-substituted glutaramide antihypertensive agents Pfizer Limited (GB) 1990-03-14 — — EP claimed
CN-1068586-C Crystalline, polymorphic form of (S,S,S)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl)tyrosine PFIZER RES & DEV CO N V S A (IE) 2001-07-18 — — CN disclosed
CN-1142816-A Crystalline, polymorphic form of (S,S,S)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl)tyrosine PFIZER LTD (IE) 1997-02-12 — — CN disclosed
WO-1995015308-A1 CRYSTALLINE, POLYMORPHIC FORM OF (S,S,S)-N-(1-[2-CARBOXY-3-(N2-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE PFIZER LIMITED (GB) 1995-06-08 — — WO disclosed
EP-0358398-B1 CYCLOALKYL-SUBSTITUTED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS Pfizer Limited (GB) 1993-03-10 — — EP disclosed
EP-0358398-A1 Cycloalkyl-substituted glutaramide antihypertensive agents Pfizer Limited (GB) 1990-03-14 — — EP disclosed